Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

about

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

Item

http://www.wikidata.org/entity/Q47279236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@en

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@nl

type

Item

label

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@en

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@nl

prefLabel

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@en

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@nl

P1476

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.

@en

P2093

I Gouni-Berthold

http://www.w3.org/2001/XMLSchema#string

J B Ernst

http://www.w3.org/2001/XMLSchema#string

J Dreier

http://www.w3.org/2001/XMLSchema#string

J F Gummert

http://www.w3.org/2001/XMLSchema#string

J Kuhn

http://www.w3.org/2001/XMLSchema#string

S Prokop

http://www.w3.org/2001/XMLSchema#string

U Fuchs

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.

Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial

Posttransplantation bone disease.

Markers of bone metabolism in congestive heart failure.

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.

Vitamin D insufficiency in congestive heart failure: why and what to do about it?

Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation

P2888

s00198-017-4312-9

P304

579-586

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-017-4312-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Heiner K Berthold

Armin Zittermann

Stefan Pilz

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29260292

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D